Relationship between overweight and obesity with the development of cardiovascular diseases
Authors:
Ján Murín 1; Udovít Gašpar 1,2
Authors‘ workplace:
I. interná klinika LF UK a UNB, Nemocnica Staré Mesto, Bratislava
1; Inštitút fyzioterapie, balneológie a liečebnej rehabilitácie (Piešťany) Univerzity sv. Cyrila a Metoda v Trnave
2
Published in:
Forum Diab 2020; 9(2): 128-131
Category:
Overview
Prevalence of overweight and obesity are increasing in the world and also in our country. Most of mortality cases in overweight and obese people is of cardiovascular (CV) origin. Some studies documented association of overweight and obesity increase with ischemic heart disease, but less so with other CV diseases. Analysis of Swedish authors of a study with Mendelian randomized character discovered association of overweight/obesity (BMI parameter) with some CV diseases by using genetic data from Biobank in UK – population of 367 703 people in the age group 40–69 ys, data during time period 2006–2010 ys. Mean age was 57 ys, 46% males, 10.3% smokers. They used 96 SNPs (genetic data, Single Nucleotide Proteins) and were able to document here 1.6% variability in BMI and 0.8% variability of characteristics of fat tissue. Genetically documented variability of BMI significantly and positively associated with 8 CV diseases: most significantly with aortic valve stenosis (relative risk: 1.13), then with heart failure (RR:1.12), and with deep venous thrombosis and hypertension (both with RR:1.10), other diseases with RR 1.07 and less, but also significant. The new result of this analysis is the documentation that overweight and obesity support development of aortic valve stenosis.
Keywords:
cardiovascular diseases – genetic analysis – obesity – overweight
Sources
Afshin A, Fofouzanfar MH, Reitsma MB et al. Health effect of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377(1): 13–27. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1614362>.
Steel N, Ford JA, Newton JN et al. Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018; 392(10158): 1647–1661. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(18)32207–4>.
Bhaskaran K, dos Santos-Silva I, Leon DA et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol 2018; 6(12): 944–953. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–8587(18)30288–2>.
Banach M, Aronow WS. Blood pressure J-curve, current concepts. Curr Hypertens Rep 2012; 14(6): 556–566. Dostupné z DOI: <http://dx.doi.org/10.1007/s11906–012–0314–3>.
Flegal K, Kit BK, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309(1): 71–82. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2012.113905>.
Di Angelantonio E, Bhupathiraju SN, Wormser D et al. [Global BMI Mortality Collaboration]. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016; 388(10046): 776–786. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(16)30175–1>.
Hägg S, Fall T, Ploner A et al. [European Network for Genetic and Genomic Epidemiology (ENGAGE) Consortium]. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol 2015; 44(2): 578–586. Dostupné z DOI: <http://dx.doi.org/10.1093/ije/dyv094>.
Dale CE, Fatemifar G, Palmer TM et al. Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus. A Mendelian randomization analysis. Circulation 2017; 135(24): 2373–2388. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.116.026560>.
Nordestgaard BG, Palmer TM, Benn M et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PloS Med 2012; 9(5): e1001212. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pmed.1001212>.
Lyall DM, Celis-Morales C, Ward J et al. Association of body mass index with cardiometabolic disease the UK BIOBANK: a Mendelian randomization study. JAMA Cardiol 2017; 2(8): 882–889. Dostupné z DOI: <http://dx.doi.org/10.1001/jamacardio.2016.5804>.
Eveborn GW, Schirmer H, Lunde P et al. Assessment of risk factors for developing incident aortic stenosis: the Trombos Study. Eur J Epidemiol 2014; 29(8): 567–575. Dostupné z DOI: <http://dx.doi.org/10.1007/s10654–014–9936-x>.
Kroll, ME, Green J, Beral V et al. Adiposity and ischemic and hemorrhagic stroke: prospective study in women and meta-analysis. Neurology 2016; 87(14): 1473–1481. Dostupné z DOI: <http://dx.doi.org/10.1212/WNL.0000000000003171>.
Stackelberg O, Bjorck M, Sadr-Azodi O et al. Obesity and abdominal aortic aneurysm. Br J Surg 2013; 100(3): 360–366. Dostupné z DOI: <http://dx.doi.org/10.1002/bjs.8983>.
Larrson SC, Bäck M, Rees JMB, et al. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J 2020; 41(2): 21–226. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehz388>.
Davey Smith G, Ebrahim S. „Mendelian randomization“: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32(1): 1–22. Dostupné z DOI: <http://dx.doi.org/10.1093/ije/dyg070>.
Sudlow C, Gallacher J, Allen N et al. UK biobank an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PloS Med 2015; 12(3): e1001779. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pmed.1001779>.
Locke AE, Dahali B, Berndt SI et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518(7538): 197–206. Dostupné z DOI: <http://dx.doi.org/10.1038/nature14177>.
Martinsson A, Ostling G, Persson M et al. Carotid plaque, intima-media thickness and incident aortic stenosis: a prospective cohort study. Arterioscler Thromb Vasc Biol 2014; 34(10): 2343–2348. Dostupné z DOI: <http://dx.doi.org/10.1161/ATVBAHA.114.304015>.
Larsson SC, Wolk A, Hakansson N, et al. Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies. Eur Heart J 2017; 38(28): 2192–2197. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehx140>.
Lindstrom S, Germain M, Crous-Bou M et al. Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. Hum Genet 2017; 136(7): 897–902. Dostupné z DOI: <http://dx.doi.org/10.1007/s00439–017–1811-x>.
Huang Y, Xu M, Xie L et al. Obesity and peripheral arterial disease: a Mendelian randomization analysis. Atherosclerosis 2016; 247: 218–224. Dostupné z DOI: <http://dx.doi.org/10.1016/j.atherosclerosis.2015.12.034>.
Fábryová Ľ. Vzťah viscerálnej obezity ku kardiometabolickým faktorom. Via Pract 2008; 5(3): 122–125. Dostupné z WWW: <http://www.viapractica.sk/index.php?page=pdf_view&pdf_id=3062&magazine_id=1>.
Yang J, Bakshi A, Zhu Z et al. Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat Genet 2015; 47(10): 1114–1120. Dostupné z DOI: <http://dx.doi.org/10.1038/ng.3390>.
Piepoli MF, Hoes AW, Agewall S et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention: & Rehabilitation (EACRP). Eur Heart J 2016; 37(29): 2315–2381. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw106>.
Engeli S, Böhnke J, Gorzelniak K et al. Weight loss and the Renin-Angiotensin-Aldosterone System. Hypertension 2005; 45(3): 356–362. Dostupné z DOI: <http://dx.doi.org/10.1161/01.HYP.0000154361.47683.d3>.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
![Issue 2](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/fe4c28c419321918ae206776329a1c37.jpeg)
Most read in this issue
- SGLT2 inhibitors in the treatment of diabetes mellitus
- Liečba inhibítormi SGLT2 u pacientov so srdcovým zlyhávaním: Čo priniesla štúdia DAPA-HF pre kardiovaskulárnu diabetológiu?
- Pathophysiological aspects of chronic heart failure
- Gliflozins and heart: Analyses of EMPRISE study